Drug Inventions
Antiviral Peptides For Treatment of the Middle East Respiratory Syndrome
Summary:
A peptide that binds to the Si spike protein of Middle East Respiratory syndrome coronavirus or MERS-CoV and a method for inhibiting infection of a subject exposed to or having MERS-CoV by administering the peptide.
Inventor Name: Dr. Musa Gabere, Dr. Ibrahim Bushnak, Dr. Hanan Balkhy, Dr. Mohamed Hussein and Dr. Sabeena Mustafa
Date of Issue: USPTO: 21, June 2022
SPO: 14, November 2023